Emma Birnie
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Long-Term Health-Related Quality of Life Outcomes in Patients With Cellulitis Requiring Hospitalisation.
Journal: The British journal of dermatology
Published: May 22, 2026
Serologic Evidence of Exposure to Burkholderia pseudomallei, Nigeria.
Journal: Emerging infectious diseases
Published: January 30, 2026
Antibodies to combat melioidosis: bridging immune mechanisms with diagnostics and therapeutic potential.
Journal: Current opinion in infectious diseases
Published: December 15, 2025
Detection of Burkholderia thailandensis in Soil Samples, Suriname.
Journal: Emerging infectious diseases
Published: September 29, 2025
Leptospirosis, melioidosis, and rickettsioses in the vicious circle of neglect.
Journal: PLoS neglected tropical diseases
Published: January 23, 2025
Cost-effectiveness Analysis of Nirmatrelvir/Ritonavir for COVID-19 Among Individuals at High Risk: A Modeling Study.
Journal: Open forum infectious diseases
Published: October 30, 2024
A Longitudinal Description of the Health-Related Quality of Life Among Individuals at High Risk After SARS-CoV-2 Infection: A Dutch Multicenter Observational Cohort Study.
Journal: Open forum infectious diseases
Published: September 15, 2024
A Robust Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T- and B-Cell Response Is Associated With Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals.
Journal: The Journal of infectious diseases
Published: February 21, 2024
Presence of Burkholderia pseudomallei in Soil, Nigeria, 2019.
Journal: Emerging infectious diseases
Published: April 20, 2023
A Graphical Overview of the Histopathology of Human Melioidosis: A Case Series.
Journal: Open forum infectious diseases
Published: March 15, 2023
Development of Resistance-Associated Mutations After Sotrovimab Administration in High-risk Individuals Infected With the SARS-CoV-2 Omicron Variant.
Journal: JAMA
Published: August 01, 2022
Last Updated: 09/26/2026